Company Details
Overview
Platform developing intranasal products to combat respiratory viruses.
Total Raised
$361 M
Rounds
6
Links
Verticals
Biotechnology
Life Science
Therapeutics
Investment History
Equity
Jun 2026
$45M
Equity
Oct 2025
$35M
Debt Financing
Jun 2025
$23M
Equity
Jan 2025
$70M
Series B
Jan 2022
$140M